Form 8-K · Current report
Elevance Health 8-K, filed Oct 21, 2026
- Filed
- CIK
- 0001156039
- Accession no.
- 0001156039-26-000068
Summary
Elevance Health reported third-quarter 2026 operating revenue of $50.4 billion, up 0.7% from a year earlier, with diluted EPS of $6.27 and adjusted diluted EPS of $6.99, and raised its full-year 2026 guidance to at least $22.00 in diluted EPS, at least $29.00 in adjusted diluted EPS, and at least $6.5 billion in operating cash flow. CEO Gail K. Boudreaux said the results reflect stronger execution across the company's portfolio and that it expects at least 12% growth in adjusted diluted EPS in 2027.
Key points
- Third-quarter 2026 operating revenue rose to $50.4 billion from $50.1 billion, with operating margin of 2.5% versus 2.6% a year earlier.
- Medical membership fell to about 44.9 million as of September 30, 2026, down 487,000 year over year, on lower Medicaid, Medicare Advantage and Employer Group risk-based enrollment.
- Carelon operating revenue rose 5% to $19.3 billion and its operating gain rose 17% to $0.9 billion, while Health Benefits operating gain declined to $0.4 billion.
- The board declared a fourth-quarter dividend of $1.72 per share, payable December 18, 2026 to shareholders of record on December 4, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 - Results of Operations and Financial Condition. On October 21, 2026, Elevance Health, Inc. issued a press release reporting its financial results for the quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. None of the information furnished in this Item 2.02 or Exhibit 99.1 hereto shall be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.